Related Experiment Video
Updated: May 6, 2026

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Ralstonia mannitolilytica Infections: A Systematic Review of Case Reports Unveiling Clinical Patterns and Therapeutic
Krishnapriya Neelambaran1, Hemasri Velmurugan1, Sajitha Venkatesan2
1Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Background:
Ralstonia mannitolilytica is an emerging opportunistic pathogen that has been increasingly reported in clinical settings. Despite its low pathogenicity in immunocompetent individuals, it poses a significant threat to immunocompromised patients, particularly those with underlying medical conditions or invasive medical interventions.
Objectives:
This study aimed to evaluate the clinical impact and management strategies based on the analysis of individual case reports on Ralstonia mannitolilytica .
Methods:
A comprehensive search of PubMed was conducted from inception until July 31, 2023, using the terms "Ralstonia mannitolilytica" and/or "Pseudomonas thomasii". Inclusion criteria for our systematic review included human-centered case reports of Ralstonia mannitolilytica infections, excluding case series and review articles. Data extraction followed PRISMA guidelines, including study details and patient characteristics. Case reports were systematically assessed using the JBI critical appraisal checklist, evaluating patient demographics, clinical history, diagnostic methods, interventions, post-intervention outcomes, adverse events, and lessons learned to minimize bias risk.
Results:
A total of 17 case reports of Ralstonia mannitolilytica infections were included in our systematic review. Studies published from 2001 to 2023 revealed diverse global contributions, with 29.41% from China. Infection origins varied, with catheter-related cases being predominant. Mortality was reported in two studies. Antibiotic sensitivity analysis showed sensitivity to third-generation cephalosporins, notably Ceftazidime. Quality appraisal revealed that all studies had a low risk of bias, ensuring the overall robustness of the case reports.
Conclusion:
This study emphasizes the importance of understanding Ralstonia mannitolilytica infections, given their varied clinical presentations and antibiotic responses. The study also underscores the necessity for precise identification, customized treatments, and ongoing research to manage these infections effectively.
Insights
Ralstonia mannitolilytica is an emerging pathogen threatening immunocompromised patients. This review of 17 case reports highlights catheter-related infections and sensitivity to third-generation cephalosporins like Ceftazidime.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Bacteriology
Background:
- Ralstonia mannitolilytica is an emerging opportunistic pathogen.
- It poses a significant threat to immunocompromised patients.
Purpose of the Study:
- To evaluate the clinical impact of Ralstonia mannitolilytica infections.
- To analyze management strategies for these infections.
Main Methods:
- Systematic review of 17 case reports from PubMed (inception-July 31, 2023).
- Data extraction followed PRISMA guidelines.
- Case reports assessed using JBI critical appraisal checklist.
Main Results:
- Catheter-related infections were predominant.
- Sensitivity observed for third-generation cephalosporins, particularly Ceftazidime.
- All included studies had a low risk of bias.
Conclusions:
- Understanding Ralstonia mannitolilytica infections is crucial due to varied presentations and responses.
- Precise identification and customized treatments are necessary.
- Ongoing research is needed for effective management.
Related Concept Videos
Mitral Stenosis III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Viral Meningitis
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis II: Pathophysiology

